Robert J. Sanchez, PhD

Regeneron Pharmaceuticals, Inc.
Tarrytown, United States

Disclosure information not submitted.

Presentation(s):

• MON-744 - Assessing the Participant Experience with Fibrodysplasia Ossificans Progressiva: Qualitative Interviews from the OPTIMA Trial

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT